FDA approves clinical testing of stem cell-based myopia treatment

02/13/2013 | Pharmaceutical Business Review Online

Advanced Cell Technology's clinical partner, the University of California, Los Angeles, obtained FDA approval for a trial to evaluate the safety of subretinal implantation of human embryonic stem cell-derived cells as a therapy for severe myopia. The study could include 12 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX